Evidence map›Paper›PMID 32674921›Full record

ArticleSchizophrenia research2020

Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder.

Milena Y Gotra, Scot K Hill, Elliot S Gershon, Carol A Tamminga, Elena I Ivleva, Godfrey D Pearlson, Matcheri S Keshavan, Brett A Clementz, Jennifer E McDowell, Peter F Buckley and 2 more

Open access · greenAbstract read
In one paragraph

Article in Schizophrenia research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Evidence for pro-cognitive benefits of cannabinoids in people with bipolar disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 1 country.

Milena Y GotraDepartment of Psychology, Rosalind Franklin University, North Chicago, IL, United States.
Scot K HillDepartment of Psychology, Rosalind Franklin University, North Chicago, IL, United States.
Elliot S GershonDepartment of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, United States.
Carol A TammingaDepartment of Psychiatry, UT-Southwestern Medical Center, Dallas, TX, United States.
Elena I IvlevaDepartment of Psychiatry, UT-Southwestern Medical Center, Dallas, TX, United States.
Godfrey D PearlsonDepartments of Psychiatry and Neuroscience, Yale University School of Medicine, New Haven, CT, United States; Institute of Living, Hartford Hospital, Hartford, CT, United States.
Matcheri S KeshavanDepartment of Psychiatry, Beth Israel Deaconness Medical Center and Harvard Medical School, Boston, MA, United States.
Brett A ClementzDepartment of Psychology and Neuroscience, University of Georgia, Athens, GA, United States.
Jennifer E McDowellDepartment of Psychology and Neuroscience, University of Georgia, Athens, GA, United States.
Peter F BuckleySchool of Medicine, Virginia Commonwealth University, Richmond, VA, United States.
John A SweeneyDepartment of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, OH, United States.
Sarah K KeedyDepartment of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, United States. Electronic address: skeedy@uchicago.edu.
Rosalind Franklin University of Medicine and Science · USUniversity of Chicago · USUniversity of Georgia · USBeth Israel Deaconess Medical Center · USSouthwestern Medical CenterThe University of Texas Southwestern Medical Center · USUniversity of Cincinnati · USVirginia Commonwealth University · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077851 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI TAMMINGA, CAROL A · 2007 to 2019
$7.8M
Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077945 · NIMH · YALE UNIVERSITY · PI PEARLSON, GODFREY D · 2007 to 2019
$7.6M
Stability of Biotypes: a Longitudinal EvaluationR01MH078113 · NIMH · WAYNE STATE UNIVERSITY · PI KESHAVAN, MATCHERI S. · 2007 to 2019
$6.2M
Stability of Biotypes: a Longitudinal Evaluation (STABLE)R01MH103368 · NIMH · UNIVERSITY OF CHICAGO · PI GERSHON, ELLIOT S, KEEDY, SARAH K · 2015 to 2019
$4.5M
5/5 BIPOLAR-SCHIZOPHRENIA NETWORK FOR INTERMEDIATE PHENOTYPES (B-SNIP) - Resubmission - 1R01MH103366 · NIMH · UNIVERSITY OF GEORGIA · PI CLEMENTZ, BRETT A, GIBBONS, ROBERT D · 2015 to 2019
$3.8M
3/4-Psychosis & Affective Research Domains and Intermediate Phenotypes (PARDIP)R01MH096957 · NIMH · YALE UNIVERSITY · PI PEARLSON, GODFREY D · 2013 to 2015
$983k
Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP)R01MH096913 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI TAMMINGA, CAROL A · 2013 to 2015
$950k
4/6 Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP)R01MH096942 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KESHAVAN, MATCHERI S. · 2013 to 2015
$783k
4/4-Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP)R01MH096900 · NIMH · UNIVERSITY OF GEORGIA · PI CLEMENTZ, BRETT A · 2013 to 2015
$223k
NCATS NIH HHS UL1 TR001863NIMH NIH HHS R01 MH077851NIMH NIH HHS R01 MH077945NIMH NIH HHS R01 MH078113NIMH NIH HHS R01 MH096900NIMH NIH HHS R01 MH096913NIMH NIH HHS R01 MH096942NIMH NIH HHS R01 MH096957NIMH NIH HHS R01 MH103366NIMH NIH HHS R01 MH103368
6 · The paper itself

Abstract

backgroundDeficits in inhibitory control on a Stop Signal Task (SST) were previously observed to be of similar magnitude across schizophrenia, schizoaffective, and bipolar disorder with psychosis, despite variation in general cognitive ability. Understanding different patterns of performance on the SST may elucidate different pathways to the impaired inhibitory control each group displayed. Comparing nonpsychotic bipolar disorder to the psychosis groups on SST may also expand our understanding of the shared neurobiology of this illness spectrum.

methodsWe tested schizophrenia (n = 220), schizoaffective (n = 216), bipolar disorder with (n = 192) and without psychosis (n = 67), and 280 healthy comparison participants with a SST and the Brief Assessment of Cognition in Schizophrenia (BACS), a measure of general cognitive ability.

resultsAll patient groups had a similar degree of impaired inhibitory control over prepotent responses. However, bipolar groups differed from schizophrenia and schizoaffective groups in showing speeded responses and inhibition errors that were not accounted for by general cognitive ability. Schizophrenia and schizoaffective groups had a broader set of deficits on inhibition and greater general cognitive deficit, which fully accounted for the inhibition deficits. No differences were found between the clinically well-matched bipolar with and without psychosis groups, including for inhibitory control or general cognitive ability.

conclusionsWe conclude that 1) while impaired inhibitory control on a SST is of similar magnitude across the schizo-bipolar spectrum, including nonpsychotic bipolar, different mechanisms may underlie the impairments, and 2) history of psychosis in bipolar disorder does not differentially impact inhibitory behavioral control or general cognitive abilities.

Indexed as

Bipolar DisorderCognition DisordersPsychotic DisordersSchizophreniaCognitionHumansBipolar disorderPsychosisResponse inhibitionSchizoaffective disorderSchizophreniaStop Signal Task

Identifiers

PMID32674921
PMCPMC7704797
OpenAlexW3042372797

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.